source
- China IIT deaths prompt lawmakers to request FDA clampdownTwo Republican lawmakers are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency, and to institute a sweeping review of existing products’…Endpoints · 17m ago↗ source
- Replimune lands commercial chief after hard-fought approval; Neumora's Paul Berns sheds CEO title→ Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer, effective Aug. 18. DiNapoli formerly worked at Genentech and led ...Endpoints · 17m ago↗ source
- How cost and perception could reshape the GLP-1 marketAs Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.